“KND Labs is thrilled and honored by this continued recognition as the premier supplier of CBD ingredients for pet products,” said KND Labs President Nich Wilson. “As the authority in animal supplements, this award from NASC underscores KND Labs’ commitment to our pet industry partners and our goal of being the most compliant certified supplier of bulk hemp-derived ingredients.”
The award comes on the heels of the groundbreaking release of a study conducted by NASC on the tolerability of CBD in dogs. Pet brands and veterinarians alike continue to promote the use of CBD oil in products for dogs, cats and other animals based on their endocannabinoid systems. The study, which has been submitted for peer review, shows the tolerability of broad spectrum cannabidiol (CBD), broad spectrum CBD with cannabigerol (CBG) and broad-spectrum CBD with cannabidiolic acid (CBDA) in healthy male and female dogs when given a daily dose for 90 consecutive days.
“Part of what makes this study unique is the data from support from the NASC’s Adverse Event Reporting System (NAERS™) which is the most advanced system of post market surveillance in the world,” said Bill Bookout, President of NASC, in announcing the study result. “Through this system, NASC members enter their products, ingredients, and administration recommendations into the NAERS database along with the number of units in each container provided to customers. These collective data are processed by algorithms in the system and Adverse Events, both serious and non-serious, can be compared and analyzed per million administrations.”
The discovery further supports the use of therapeutic CBD in healthy dogs, which often is used in response to animals with seizures, anxiety, pain, skin issues, and other physical and neurological issues.
“Partnering with a trustworthy CBD supply chain partner is critical for producers of pet supplements and other pet industry products,” said KND Labs Manager of Sales, Courtlandt Pennell. “Having now earned the NASC MVP supplier award for two years running, KND Labs has shown time and again our commitment to compliance and quality for our partners in the pet industry and across all the industries we serve.”
In addition to its NASC supplier status, KND Labs is also NSF, cGMP 111 and 117, euGMP Effci ISO 9001, Kosher-certified and is certified as an API (Active Pharmaceutical Ingredients) manufacturer for the pharmaceutical industry and for OTC applications.
About KND Labs
KND Labs is a leading manufacturer of hemp-derived ingredients, extracting quality bulk ingredients for brands and manufacturers of both human and pet products. Focused on certification and compliance in the CBD market, KND is a preferred NASC supplier, EFFCI eGMP, 21 CFR PART 117 cGMP, 21 CFR Part 111 cGMP, ISO 9001:2105 certified, API certified, NSF certified, USDA Organic certified and Kosher certified. KND is also an active member of the European Industrial Hemp Association (EIHA) and an FDA Drug Establishment. With two state-of-the-art facilities in Lakewood, Colo. and Arvada, Colo., KND Labs produces hemp-derived cannabinoids such as CBD, CBG, and other hemp-derived cannabinoids in powdered isolate form, distillate oil form and liquid or powder water-soluble form. Learn more at kndlabs.com.